Reviewed by Laurence P. Banville, Esq.Frequently asked questions
What injuries are linked to Glyxambi lawsuits?
Glyxambi combines an SGLT2 inhibitor (empagliflozin) and a DPP-4 inhibitor (linagliptin), and has been associated with diabetic ketoacidosis (DKA), urinary tract infections, genital yeast infections, Fournier’s gangrene, and acute kidney injury. Plaintiffs in Glyxambi litigation allege that Boehringer Ingelheim and Eli Lilly failed to adequately warn prescribing physicians and patients about these risks. If you or a loved one suffered one of these conditions after taking Glyxambi, you may have grounds for a product liability claim in New York.
Who can file a Glyxambi lawsuit in New York?
New York residents who took Glyxambi and suffered serious complications — such as DKA, kidney failure, or Fournier’s gangrene — may be eligible to file suit against the drug’s manufacturers. Claims typically proceed under product liability theories: defective design, failure to warn, and negligence. Family members may also bring a wrongful death claim if a loved one died from a Glyxambi-related complication. An attorney can review your medical records and prescribing history to assess eligibility.
How long do I have to file a Glyxambi lawsuit in New York?
Under CPLR §214, New York’s general personal injury statute of limitations is three years from the date of injury or the date you reasonably discovered the injury was caused by the drug. In pharmaceutical cases, the discovery rule can extend this window if the connection between Glyxambi and your condition was not immediately apparent. Missing this deadline typically bars your claim entirely, so it is critical to consult a NY attorney as soon as possible.
What should I do if I was harmed by Glyxambi in New York?
First, seek medical care and document all diagnoses, hospitalizations, and treatments related to your condition. Preserve your prescription records, pharmacy receipts, and any communications with your doctor about Glyxambi. Then contact a New York personal injury attorney experienced in pharmaceutical litigation before the three-year statute of limitations expires. An attorney can investigate the manufacturer’s conduct, gather expert medical opinions, and determine whether your case is best pursued individually or as part of multidistrict litigation.